Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers
Epigenetic modifiers acting through polypharmacology mechanisms are promising compounds with which to treat several infectious diseases. Histone deacetylase (HDAC) enzymes, mainly class I, and extra-terminal bromodomains (BET) are involved in viral replication and the host response. In the present s...
Saved in:
Main Authors: | Juliana Romano Lopes (Author), Igor Muccilo Prokopczyk (Author), Max Gerlack (Author), Chung Man Chin (Author), Jean Leandro Dos Santos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach
by: Jean Leandro dos Santos, et al.
Published: (2011) -
Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
by: Beatriz Silva Urias, et al.
Published: (2022) -
High-Throughput Screening for Epigenetic Compounds That Induce Human β-Defensin 1 Synthesis
by: Wentao Lyu, et al.
Published: (2023) -
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds
by: Guilherme Felipe dos Santos Fernandes, et al.
Published: (2017) -
PP 3.20 - 00154 Epigenetic modifying compounds negatively impact viral replication within primary human macrophages
by: G. Lê-Bury, et al.
Published: (2022)